AI
ABVX

Atria Investments’s Abivax ABVX Stock Holding History

Atria Investments’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$667K Buy
5,992
+190
+3% +$22.5K 0.01% 1291
2025
Q4 		$782K Buy
+5,802
New +$633K 0.01% 1199

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Atria Investments's ABVX Position: Q1 2026 in Review

Atria Investments increased its Abivax (ABVX) stake by 3.3% in Q1 2026, buying an estimated $22.5K and bringing the position to 5,992 shares worth $667K. The position accounts for 0.01% of the portfolio, ranked #1291.

Atria Investments first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. The position peaked at $782K in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Atria Investments held 5,992 shares of Abivax worth $667K as of Q1 2026.
  • Atria Investments bought 190 Abivax shares in Q1 2026, an estimated $22.5K.
  • Abivax made up 0.01% of Atria Investments's portfolio in Q1 2026, its #1291 holding.
  • Atria Investments first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • Atria Investments's Abivax position peaked at $782K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.